On Tuesday, Immix Biopharma Inc (NASDAQ: IMMX) opened lower -18.85% from the last session, before settling in for the closing price of $2.60. Price fluctuations for IMMX have ranged from $1.26 to $2.71 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 13.64% at the time writing. With a float of $16.60 million, this company’s outstanding shares have now reached $27.85 million.
The extent of productivity of a business whose workforce counts for 21 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Immix Biopharma Inc (IMMX) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Immix Biopharma Inc is 40.45%, while institutional ownership is 10.92%. The most recent insider transaction that took place on Dec 23 ’24, was worth 87,680. In this transaction Director of this company bought 40,000 shares at a rate of $2.19, taking the stock ownership to the 893,000 shares. Before that another transaction happened on Dec 20 ’24, when Company’s Director bought 7,700 for $2.17, making the entire transaction worth $16,678. This insider now owns 853,000 shares in total.
Immix Biopharma Inc (IMMX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 13.64% per share during the next fiscal year.
Immix Biopharma Inc (NASDAQ: IMMX) Trading Performance Indicators
Check out the current performance indicators for Immix Biopharma Inc (IMMX). In the past quarter, the stock posted a quick ratio of 1.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.72 and is forecasted to reach -0.87 in one year’s time.
Technical Analysis of Immix Biopharma Inc (IMMX)
The latest stats from [Immix Biopharma Inc, IMMX] show that its last 5-days average volume of 0.59 million was superior to 0.14 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 64.09%. Additionally, its Average True Range was 0.27.
During the past 100 days, Immix Biopharma Inc’s (IMMX) raw stochastic average was set at 46.39%, which indicates a significant increase from 21.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 157.24% in the past 14 days, which was higher than the 88.64% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.89, while its 200-day Moving Average is $1.88. Now, the first resistance to watch is $2.78. This is followed by the second major resistance level at $3.46. The third major resistance level sits at $3.91. If the price goes on to break the first support level at $1.65, it is likely to go to the next support level at $1.20. Assuming the price breaks the second support level, the third support level stands at $0.52.
Immix Biopharma Inc (NASDAQ: IMMX) Key Stats
There are currently 27,877K shares outstanding in the company with a market cap of 58.82 million. Presently, the company’s annual sales total 0 K according to its annual income of -21,610 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -4,540 K.
